Advertising
Showing 1 to 15 of 194 entries
COMMENT

Rates this as C+ in his system, but is probably going to have to upgrade that. Revenue is starting to accelerate. Have a new management team on board that is basically focusing the company and going for profitable business, instead of just doing acquisitions. Last quarter was very, very solid. Stock is up 174% in this last year and is starting to get noticed again.

biotechnology / pharmaceutical
SELL
Low margin business and has been decimated over time. Sees nothing that would tempt him to Buy. If you own, consider selling and moving on to something else.
biotechnology / pharmaceutical
COMMENT
Had some challenges over the last few years. Recently been on a recovery path of straightening out operations and lowering costs. There has been an unsolicited takeover bid. Need to continue executing on their current strategy. Worth a look.
biotechnology / pharmaceutical
HOLD
(Market Call Minute.) You have to be careful of them, as they have had execution issues over time.
biotechnology / pharmaceutical
COMMENT
Relatively risky but the company has made a lot of the right moves. Grew very fast but like a lot of companies, had problems with some of their acquisitions. Have a pretty high cost structure. Thinks the worst is over. On a five-year timeframe, the trend for outsourcing is still there.
biotechnology / pharmaceutical
HOLD
(Market call minute.) New management. Closing operations. In a turn around phase.
biotechnology / pharmaceutical
DON'T BUY
(Market Call Minute.) Model price is $2.75, a -13% differential.
biotechnology / pharmaceutical
COMMENT
Made a big acquisition about 2 years ago, which basically almost blew the company up. There were a lot of money-losing contracts that they have been trying to clean up. Eventually it will probably turn around, but the question is will they get it done in 08 or 09.
biotechnology / pharmaceutical
PAST TOP PICK

(Top Short) Then 5.50 Had a premium valuation that they no longer deserved. He shorted and it paid for him. It's going to be a long hard turn around.

biotechnology / pharmaceutical
PAST TOP PICK
Then 5.95 Stop loss at 5 20. If a stock goes below the stop loss, then if it doesn't recover within a week, it's time to move on. Don't buy right now. Bottom fishing.
biotechnology / pharmaceutical
SELL
Big disappointment to investors. Doesn’t see any prospects for an immediate recovery. Earnings forecasts for the next year or so are only in the $.20 range.
biotechnology / pharmaceutical
DON'T BUY
This was one of her most successful Shorts last year. Would not be a buyer.
biotechnology / pharmaceutical
PAST TOP PICK
(A Top Pick Aug 11/06. Down 8.1%.) It is probably at the bottom of a trading range and it will probably work up to the upper band.
biotechnology / pharmaceutical
DON'T BUY
This is not a stock that you want to look at. It couldn't rally with The market that we had over the last 4 years. A bottom fish play.
biotechnology / pharmaceutical
DON'T BUY
A beat up company that deserves to be beaten up. Porto Rico acquisition turned extremely sour. Have had a revolving door in the executive office. Large debt.
biotechnology / pharmaceutical
Showing 1 to 15 of 194 entries

Patheon(PTI-T) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Patheon is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Patheon(PTI-T) Frequently Asked Questions

What is Patheon stock symbol?

Patheon is a OTC stock, trading under the symbol PTI-T on the (). It is usually referred to as or PTI-T

Is Patheon a buy or a sell?

In the last year, there was no coverage of Patheon published on Stockchase.

Is Patheon a good investment or a top pick?

Patheon was recommended as a Top Pick by on . Read the latest stock experts ratings for Patheon.

Why is Patheon stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Patheon worth watching?

0 stock analysts on Stockchase covered Patheon In the last year. It is a trending stock that is worth watching.

What is Patheon stock price?

On , Patheon (PTI-T) stock closed at a price of $.